1. Home
  2. BGC vs ADMA Comparison

BGC vs ADMA Comparison

Compare BGC & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGC
  • ADMA
  • Stock Information
  • Founded
  • BGC 1945
  • ADMA 2004
  • Country
  • BGC United States
  • ADMA United States
  • Employees
  • BGC N/A
  • ADMA N/A
  • Industry
  • BGC Investment Bankers/Brokers/Service
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BGC Finance
  • ADMA Health Care
  • Exchange
  • BGC Nasdaq
  • ADMA Nasdaq
  • Market Cap
  • BGC 4.3B
  • ADMA 5.1B
  • IPO Year
  • BGC 1999
  • ADMA N/A
  • Fundamental
  • Price
  • BGC $10.85
  • ADMA $18.67
  • Analyst Decision
  • BGC Strong Buy
  • ADMA Strong Buy
  • Analyst Count
  • BGC 2
  • ADMA 3
  • Target Price
  • BGC $14.50
  • ADMA $27.67
  • AVG Volume (30 Days)
  • BGC 3.4M
  • ADMA 3.5M
  • Earning Date
  • BGC 07-31-2025
  • ADMA 08-07-2025
  • Dividend Yield
  • BGC 0.74%
  • ADMA N/A
  • EPS Growth
  • BGC 128.63
  • ADMA N/A
  • EPS
  • BGC 0.27
  • ADMA 0.84
  • Revenue
  • BGC $2,252,851,000.00
  • ADMA $459,381,000.00
  • Revenue This Year
  • BGC $35.79
  • ADMA $23.35
  • Revenue Next Year
  • BGC $9.83
  • ADMA $27.67
  • P/E Ratio
  • BGC $40.88
  • ADMA $21.87
  • Revenue Growth
  • BGC 13.24
  • ADMA 62.23
  • 52 Week Low
  • BGC $7.24
  • ADMA $10.21
  • 52 Week High
  • BGC $11.79
  • ADMA $25.67
  • Technical
  • Relative Strength Index (RSI)
  • BGC 75.90
  • ADMA 41.64
  • Support Level
  • BGC $9.13
  • ADMA $17.67
  • Resistance Level
  • BGC $9.85
  • ADMA $18.92
  • Average True Range (ATR)
  • BGC 0.28
  • ADMA 0.77
  • MACD
  • BGC 0.12
  • ADMA -0.05
  • Stochastic Oscillator
  • BGC 98.56
  • ADMA 22.25

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: